论文部分内容阅读
东北三省及内蒙古自治区日前联合开展公立医疗机构药品采购“两票制”有关问题界定工作。界定范围涉及4类企业,即参加东北三省及内蒙古自治区药品集中采购中标(含挂网)的科工贸一体化的集团型企业、境外药品的国内总代理(全国仅限1家国内总代理)、药品流通集团型企业及药品上市许可持有人。
The three northeastern provinces and Inner Mongolia Autonomous Region jointly conducted the work of defining the issues related to the drug purchase and “two-vote system” of public medical institutions. The scope of the definition involves four types of enterprises, that is, to participate in centralized procurement of drugs in the three northeastern provinces and Inner Mongolia Autonomous Region (including net) Division of industry and trade integration of group-based enterprises, the domestic distributor of foreign drugs (the country is limited to a domestic distributor) , Pharmaceutical distribution group-type enterprises and drug listing license holders.